Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5Y49C | — |
she administered the first vial, just the suspension liquid; she administered the first vial, just the suspension liquid; 46 year old received Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 46-year-old male patient who received Herpes zoster (Shingrix) (batch number 5Y49C) for prophylaxis. On 30-JUN-2025, the patient received Shingrix. On 30-JUN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: she administered the first vial, just the suspension liquid), inappropriate dose of vaccine administered (Verbatim: she administered the first vial, just the suspension liquid) and inappropriate age at vaccine administration (Verbatim: 46 year old received Shingrix). The outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and inappropriate age at vaccine administration were not applicable. Additional Information: GSK receipt date: 30-JUN-2025 Other HCP reported that a patient was due to the Shingrix vaccine and the medical assistant who administered the vaccine did not reconstitute with the second vial, she administered the first vial, just the suspension liquid. Reporter asked if they go ahead and make another vaccine reconstituted and administer to the patient on the day of reporting and will they be any adverse effects if they do that. The patient received only 1 vial of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.